We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




VR and AI Drive Exponential Growth in Integrated Operating Rooms

By MedImaging International staff writers
Posted on 06 Jul 2019
Print article
The operating room (OR) is transforming from a seemingly simple box into a technology-powered, infection-free, and sleek surgical environment. The new-age OR will be able to utilize intelligent and efficient delivery options to improve the precision and predictability of the services offered. This can be made possible through robotic-assisted surgery devices (RASDs), which will greatly help drive the USD 4.50 billion and EU5 hospital OR products and solutions market toward USD 7.04 billion by 2022.

These are the findings of a latest analysis of the US and EU5 hospital OR products and solutions market by Frost & Sullivan (Santa Clara, CA, USA), a growth strategy consulting and research firm. The study analyzes the impact of robotics and workflow solutions on the quality and quantitative measures in the ORs and covers workflow solutions, surgical components in the workplace, and OR room services.

The OR services segment is highly fragmented and has more potential in Europe than the US; however, approximately 70% to 75% of the major hospitals have adopted OR management solutions across both countries. According to the study, for more growth opportunities, market participants can:
• Foster partnerships with medical device and technology companies to deliver products and services across a larger customer base.
• Adopt virtual reality (VR) in medicine to increase volumes of well-planned and cost-effective precision surgeries.
• Employ Artificial Intelligence (AI) algorithms. For instance, Google is investigating predictive analytics to reduce readmission and identify potential patient risks.
• Provide patient-centric services that are not necessarily aligned to clinical outcomes.
"By 2022, 35% to 45% of ORs across the world will become integrated ORs. After 2030, with the availability of multiple home care devices, ORs will shift toward a hub-and-spoke model, with the OR being the hub," said Bejoy Daniel, Senior Industry Analyst, Transformational Health. "Approximately USD 30 billion worth of integration opportunities are likely to become available to healthcare and non-healthcare companies by this period when ORs make the transition from regular rooms to an integrated environment."

"Currently, the priority for vendors is to analyze the available data and facilitate connectivity for device integration. The aim is to interpret, synchronize, and coordinate data to achieve optimal OR results," added Daniel. "Data interoperability will help analyze past and present data to predict future health outcomes and patient wellness index for optimum use of resources. The shift in favor of data and algorithms will fuel the algorithmic business and endow businesses with a competitive edge."

Related Links:
Frost & Sullivan

Radiology Software
DxWorks
Ultrasound Imaging System
P12 Elite
Ultrasonic Pocket Doppler
SD1
New
Needle Guide Disposable Kit
Verza

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.